Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baron Capital is a premier asset management firm founded in 1982 by Ron Baron, specializing in long-term growth equity investment solutions. The firm is widely recognized for its fundamental, research-driven approach and its suite of mutual funds, most notably the Baron Health Care Fund, which targets high-growth companies across the biotechnology, pharmaceutical, and medical technology sectors. Headquartered in New York City, Baron Capital manages approximately $49 billion in assets and maintains a high-conviction portfolio of businesses with sustainable competitive advantages. The firm's healthcare strategy focuses on innovative companies solving critical medical challenges, including leaders in GLP-1 therapies, rare diseases, and life science tools. Baron Capital is known for its long-term investment horizon, often holding positions for a decade or more to capture full growth potential.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baron Funds.